Search research articles
Contact Us
Filters
Showing results (21-30 of 215) with videos related to
Page
of 22
Sort By:
Nature Reviews. Cancer
|
October 25, 2007
MLL translocations, histone modifications and leukaemia stem-cell development
Andrei V Krivtsov, Scott A Armstrong
Current Drug Targets
|
June 23, 2007
FLT3 as a therapeutic target in childhood acute leukemia
Matthew C Stubbs, Scott A Armstrong
Epigenomics
|
December 1, 2011
A role for DOT1L in MLL-rearranged leukemias
Kathrin M Bernt, Scott A Armstrong
Hematology. American Society of Hematology. Education Program
|
December 14, 2011
Targeting epigenetic programs in MLL-rearranged leukemias
Kathrin M Bernt, Scott A Armstrong
Nature
|
November 29, 2013
Stem cells: Dual response to Ras mutation
S Haihua Chu, Scott A Armstrong
Seminars in Hematology
|
September 12, 2025
Menin inhibition for the treatment of acute leukemia
Daniela V Wenge, Scott A Armstrong
Experimental Hematology
|
June 30, 2015
Targeting DOT1L and HOX gene expression in MLL-rearranged leukemia and beyond
Chun-Wei Chen, Scott A Armstrong
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 1, 2008
Cancer stem cells in hematopoietic malignancies
Richard J Jones, Scott A Armstrong
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2007
Therapeutic implications of leukemia stem cell development
Matthew C Stubbs, Scott A Armstrong
Plos One
|
March 7, 2012
iCanPlot: visual exploration of high-throughput omics data using interactive Canvas plotting
Amit U Sinha, Scott A Armstrong
Page
of 22
Search research articles
Search
Showing results (21-30 of 215) with videos related to
Sort By:
Page
of 22
Nature Reviews. Cancer
|
October 25, 2007
MLL translocations, histone modifications and leukaemia stem-cell development
Andrei V Krivtsov, Scott A Armstrong
Current Drug Targets
|
June 23, 2007
FLT3 as a therapeutic target in childhood acute leukemia
Matthew C Stubbs, Scott A Armstrong
Epigenomics
|
December 1, 2011
A role for DOT1L in MLL-rearranged leukemias
Kathrin M Bernt, Scott A Armstrong
Hematology. American Society of Hematology. Education Program
|
December 14, 2011
Targeting epigenetic programs in MLL-rearranged leukemias
Kathrin M Bernt, Scott A Armstrong
Nature
|
November 29, 2013
Stem cells: Dual response to Ras mutation
S Haihua Chu, Scott A Armstrong
Seminars in Hematology
|
September 12, 2025
Menin inhibition for the treatment of acute leukemia
Daniela V Wenge, Scott A Armstrong
Experimental Hematology
|
June 30, 2015
Targeting DOT1L and HOX gene expression in MLL-rearranged leukemia and beyond
Chun-Wei Chen, Scott A Armstrong
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 1, 2008
Cancer stem cells in hematopoietic malignancies
Richard J Jones, Scott A Armstrong
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2007
Therapeutic implications of leukemia stem cell development
Matthew C Stubbs, Scott A Armstrong
Plos One
|
March 7, 2012
iCanPlot: visual exploration of high-throughput omics data using interactive Canvas plotting
Amit U Sinha, Scott A Armstrong
Page
of 22